PSNL Personalis Inc

BTIG analyst Mark Massaro reiterated a Buy rating on Personalis (PSNL - Research Report) yesterday and set a price target of $8.00. The company's shares closed yesterday at $2.70.Massaro covers the Healthcare sector, focusing on stocks such as Castle Biosciences, T2 Biosystems, and Natera. According to TipRanks, Massaro has an average return of -4.3% and a 40.28% success rate on recommended stocks. In addition to BTIG, Personalis also received a Buy from H.C. Wainwright's Swayampakula Ramakanth in a report issued yesterday. However, on the same day, Needham maintained a Hold rating on Personalis (NASDAQ: PSNL).
https://www.tipranks.com/news/blurbs/btig-sticks-to-their-buy-rating-for-personalis-psnl?utm_source=advfn.com&utm_medium=referral